We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Really quite an excellent article that. Intelligently written and positive to hemo. I needed that to lift my spirits, takes my mind off the crap sp.
Many positives, 2 or 3 results hopefully by Dec, more testing after would be by non-dilutive means, lots of interested parties in discussions about developing CBR. All sounds amazing to me. Happy to wait it out...
Have to say I’m very happy Vlad has moved away from Burton and TMS towards Proactive. A very good update !
What do you expect!!!...2 months after CH lifted and still no news.... everything just drags on so slow with hemogenyx tat shareholders get fed up and move on. At this price no shareholder is showing a profit
😳
Just so much selling - I don't understand at all :(
Unfortunately, it’s still not stopping many muppets selling well under 2p. It’s certainly unfathomable to me 🤷😳
Now if that doesn't reassure MrI (and anyone considering investing in Hemo), not easy to see what would!
It wasnt me who found it - Forwarded on by a certain poster who is currently absent from the chat forum - But thought I would share
Thanks Haywain.......great find and very helpful. Cheers
Fact is one, two or three patients may well be enough to garner significant interest depending on the outcomes - So I read it very positively.
This is an interesting excerpt - perhaps helps to explain why Hemo have achieved what they have on such a shoestring budget"The entre was provided by Professor Carl June, the ‘father’ of CAR-T, and his colleague, Dr Saar Gill, who was involved in the preclinical research on HEMO-CAR-T.
On the university’s involvement, Sandler said: “This isn’t a situation where we’ve paid [UPenn] to carry out the work. They don’t work like that. All along it been data driven.”"
Haywain, very interesting article, thanks for posting. Which is why I’m shocked we are as low as we are currently. When this bounces, and it will, we will be many multiples of today’s price. It’s been a painful wait, but I believe it’ll be worth it in the end
Great spot, thanks for posting. Very positive. Need that first slice of good news to spring forth...
Yes interesting, but this didn't inspire me with very few patients being treated...
Under the strict guidelines laid down by the US Food & Drug Administration, patients will be dosed individually one month apart, recognising people are being administered with a potentially toxic cells.
Hemogenyx hopes to have the results from “two, or even three patients” in time for the American Society of Hematology conference in early December.
Give me a shout when it's blue.....I'll wait...looks like that was JHFHs ISA bed and breakfast gone through today....it's the first I have seen
Settling well here, soon be blue
Appreciated replier. I would suggest this board is a good place to start one’s research. Looking back at people’s reactions/behaviours/psychology all the way to February when the SP dropped is a good indication of how the people feel about this one. Priceless in fact.
Good summary PJT in the link - Thanks I enjoyed that.
I had to laugh at the post below, "What's the potential of this company?" That was the entire post, so good to see that the poster is keen to cut down the need for any of that pesky research stuff. "Billions" came the reply, which is potentially true but - for me at least - doesn't quite cover the whole story ;-)
This might make a good starting point for the questioner:
https://www.cancer.gov/about-cancer/treatment/research/car-t-cells
...or at least a stepping stone along the way.
One good update and this will fly. CAR T is the future.
Surely some sort of news fairly soon
Yes Saint but not for very long